These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 33920915)

  • 1. The Emerging Role of Epigenetic Mechanisms in the Causation of Aberrant MMP Activity during Human Pathologies and the Use of Medicinal Drugs.
    Sarker H; Haimour A; Toor R; Fernandez-Patron C
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33920915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases.
    Castro MM; Kandasamy AD; Youssef N; Schulz R
    Pharmacol Res; 2011 Dec; 64(6):551-60. PubMed ID: 21689755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonantimicrobial effects of tetracyclines].
    García-Alvarez L; Oteo JA
    Rev Esp Quimioter; 2010 Mar; 23(1):4-11. PubMed ID: 20232018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Doxycycline or how to create new with the old?].
    Shehwaro N; Langlois AL; Gueutin V; Gauthier M; Casenave M; Izzedine H
    Therapie; 2014; 69(2):129-41. PubMed ID: 24926631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic and Adverse Effects of Statins-Do Epigenetics Play a Role?
    Allen SC; Mamotte CDS
    J Pharmacol Exp Ther; 2017 Aug; 362(2):319-326. PubMed ID: 28576976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
    Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
    J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.
    Fanjul-Fernández M; Folgueras AR; Cabrera S; López-Otín C
    Biochim Biophys Acta; 2010 Jan; 1803(1):3-19. PubMed ID: 19631700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins: Epidrugs with effects on endothelial health?
    Mohammadzadeh N; Montecucco F; Carbone F; Xu S; Al-Rasadi K; Sahebkar A
    Eur J Clin Invest; 2020 Dec; 50(12):e13388. PubMed ID: 32854143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline and other tetracyclines in the treatment of bone metastasis.
    Saikali Z; Singh G
    Anticancer Drugs; 2003 Nov; 14(10):773-8. PubMed ID: 14597870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of MMPs during melanoma progression: from genetic to epigenetic.
    Frank A; David V; Aurelie TR; Florent G; William H; Philippe B
    Anticancer Agents Med Chem; 2012 Sep; 12(7):773-82. PubMed ID: 22292748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.
    Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T
    Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetracyclines: nonantibiotic properties and their clinical implications.
    Sapadin AN; Fleischmajer R
    J Am Acad Dermatol; 2006 Feb; 54(2):258-65. PubMed ID: 16443056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
    Walker NF; Clark SO; Oni T; Andreu N; Tezera L; Singh S; Saraiva L; Pedersen B; Kelly DL; Tree JA; D'Armiento JM; Meintjes G; Mauri FA; Williams A; Wilkinson RJ; Friedland JS; Elkington PT
    Am J Respir Crit Care Med; 2012 May; 185(9):989-97. PubMed ID: 22345579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.
    Curci JA; Mao D; Bohner DG; Allen BT; Rubin BG; Reilly JM; Sicard GA; Thompson RW
    J Vasc Surg; 2000 Feb; 31(2):325-42. PubMed ID: 10664501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
    Varghese S
    Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The matrix metalloproteinases as pharmacological target in osteoarthritis: statins may be of therapeutic benefit.
    Wu YS; Hu YY; Yang RF; Wang Z; Wei YY
    Med Hypotheses; 2007; 69(3):557-9. PubMed ID: 17360129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.
    Olejarz W; Łacheta D; Kubiak-Tomaszewska G
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinases and their inhibitors in neurological disease.
    Lopez-Navarro ER; Gutierrez J
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):27-38. PubMed ID: 34851449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.
    Araki Y; Mimura T
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28441353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.